
Please try another search
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprising instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent probe binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples. In addition, the company offers reagent kits, which include sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was founded in 2016 and is headquartered in Seattle, Washington.
Name | Age | Since | Title |
---|---|---|---|
Melissa B. Epperly | 43 | 2021 | Independent Director |
Matthew McIlwain | 56 | 2021 | Independent Director |
Matthew L. Posard | 54 | 2021 | Independent Chairman of the Board |
Sujal M. Patel | 47 | 2021 | Co-Founder, CEO, President, Secretary & Director |
Parag Mallick | 44 | 2021 | Co-Founder, Chief Scientist & Director |
Karen Akinsanya | 57 | 2022 | Independent Director |
Joshua LaBaer | - | - | Member of Scientific Advisory Board |
Emma Lundberg | - | 2021 | Member of Scientific Advisory Board |
Ruedi Aebersold | - | - | Member of Scientific Advisory Board |
Leland H. Hartwell | - | - | Member of Scientific Advisory Board |
Farzad Nazem | 63 | 2021 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review